Our Services
Dermicus Diagnostic Support

Gnosco offer a digital diagnostic support platform for faster and more secure diagnosis of skin lesions and wounds. The CE-certified platform, Dermicus, provides a faster and more efficient medical process, improved patient experience and is specifically aimed for communication between healthcare providers. In addition, Dermicus is also a continuous E-learning platform for doctors and nurses. Total costs are decreased due to fewer excisions and less physical referrals to specialists, but most important diagnoses are set much faster than before.

Dermicus Diagnostic Support

Gnosco offer a digital diagnostic support platform for faster and more secure diagnosis of skin lesions and wounds. The CE-certified platform, Dermicus, provides a faster and more efficient medical process, improved patient experience and is specifically aimed for communication between healthcare providers. In addition, Dermicus is also a continuous E-learning platform for doctors and nurses. Total costs are decreased due to fewer excisions and less physical referrals to specialists, but most important diagnoses are set much faster than before.

Dermicus Education

Gnosco offer an education program for both First Line Clinicians (General Practitioners) and Dermatology Specialists. The program aims to improve knowledge about Malignant Melanoma and other related skin-diseases. The education program consist of online course, face-to-face course, and continuous learning.

About us

DERMICUS telemedicine platform was founded by Dr Johan Heilborn. Dr Heilborn identified from his work at the Karolinska Hospital, Sweden, that he could improve patient care and increase efficiency by using emerging mobile applications and digital platforms to improve the quality and speed of skin cancer diagnosis. Dr Heilborn also recognised that if such a solution was implemented, with complementary training and with continuous learning from the start, clinicians would adopt the new technology. This commitment to easy implementation, training and continuous learning remains at the heart of Gnosco today.

NOW Gnosco is a fast growing company within the global digital health industry. The team is constantly growing and based in several locations. Also wound, and specifically slow healing wound, is added as an area of focus for Gnosco. Due to that fact that Gnosco has been active on the Swedish market for so long, a lot of structured data is already gathered. This data is now the basis for ongoing AI development features and products. The future lies ahead and we continue to strive for our mission to prevent unnecessary death, set correct diagnosis and do it more efficiently than today.

Latest news
July 02, 2021
Min Doktor has implemented Dermicus
Read more
June 30, 2021
Henric Carlsson new member of the board
Read more
April 08, 2021
Gnosco and Min Doktor initiates a collaboration
Read more
March 24, 2021
Dermicus NHS team finalists addressing skin cancer in the HSJ Awards
Read more
January 27, 2021
The IOW NHS in UK and Region Stockholm Sweden first to implement Dermicus for all health centres
Read more
November 20, 2020
Shortlisted for NHS Primary Care Innovation of the Year
Read more
October 19, 2020
Implementation of Dermicus Wound EWMA 2020
Read more
October 17, 2020
Dermicus passes NHS Digital assurance to help with coronavirus
Read more
July 14, 2020
The use of Dermicus during COVID-19
Read more
July 20, 2019
Several projects and agreements in UK during spring 2019
Read more
May 03, 2019
Gnosco participate at EWMA – the biggest wound conference in Europe
Read more
April 03, 2019
Gnosco on the way to Australia
Read more
June 28, 2018
Gnosco attending British Association of Dermatologists annual meeting
Read more
May 27, 2018
Launch of Dermicus NEW mobile application
Read more
January 10, 2018
New AI project together with KTH and Karolinska University Hospital
Read more
November 28, 2017
Partnership with Swedish Registries of Ulcer Treatment
Read more